Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges.
作者信息
McMahon Brian J
机构信息
Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Anchorage AK.
出版信息
Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):29-32. doi: 10.1002/cld.733. eCollection 2018 Jul.
Abstract
摘要
相似文献
1
Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges.实现世界卫生组织和美国到2030年消除乙型肝炎感染的目标：机遇与挑战。
Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):29-32. doi: 10.1002/cld.733. eCollection 2018 Jul.
2
Low Prevalence of Hepatitis B Vaccination Among Patients Receiving Medical Care for HIV Infection in the United States, 2009 to 2012.2009 年至 2012 年美国接受艾滋病毒感染医疗护理的患者中乙型肝炎疫苗接种率较低。
Ann Intern Med. 2018 Feb 20;168(4):245-254. doi: 10.7326/M17-1689. Epub 2017 Dec 26.
3
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.第三届国际艾滋病毒/病毒性肝炎合并感染会议亮点——艾滋病毒/病毒性肝炎：改善诊断、抗病毒治疗及可及性
Hepatol Med Policy. 2017 Apr 20;2:8. doi: 10.1186/s41124-017-0025-0. eCollection 2017.
4
[Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].[中国在实现世界卫生组织“2030年消除乙型肝炎”目标方面的进展与挑战]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jun 10;40(6):605-609. doi: 10.3760/cma.j.issn.0254-6450.2019.06.001.
5
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.消除乙型肝炎病毒和丙型肝炎病毒作为全球健康威胁需要什么。
Gastroenterology. 2019 Jan;156(2):297-310. doi: 10.1053/j.gastro.2018.10.048. Epub 2018 Nov 2.
6
Eradicating hepatitis B virus: The critical role of preventing perinatal transmission.消除乙型肝炎病毒：预防围产期传播的关键作用。
Biologicals. 2017 Nov;50:3-19. doi: 10.1016/j.biologicals.2017.08.008. Epub 2017 Sep 2.
7
Current status and strategies for viral hepatitis control in Korea.韩国病毒性肝炎防控的现状与策略。
Clin Mol Hepatol. 2017 Sep;23(3):189-195. doi: 10.3350/cmh.2017.0033. Epub 2017 Sep 19.
8
Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.利用催化资金模式推进乙肝和丙肝消除工作-乌兹别克斯坦塔什干，2019 年 12 月 6 日至 2020 年 3 月 15 日。
MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1161-1165. doi: 10.15585/mmwr.mm6934a3.
9
10
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.在美国消除乙肝病毒感染传播的综合免疫策略：免疫实践咨询委员会（ACIP）的建议 第二部分：成人免疫接种
MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4.
引用本文的文献
1
Persisting challenges in the early detection of hepatocellular carcinoma.肝细胞癌早期检测中持续存在的挑战。
Expert Rev Anticancer Ther. 2025 Feb 24:1-12. doi: 10.1080/14737140.2025.2467184.
2
Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.全球乙肝相关肝病负担：2000年至2021年期间，全球超过三分之一的国家因慢性乙肝感染导致的原发性肝癌有所增加。
Hepatology. 2025 Feb 11. doi: 10.1097/HEP.0000000000001260.
3
Patient Source of Referral Is a Key Determinant of Subsequent Retention in Care for Young Chronic Hepatitis B Patients.患者的转诊来源是年轻慢性乙型肝炎患者后续坚持治疗的关键决定因素。
J Viral Hepat. 2025 Feb;32(2):e14059. doi: 10.1111/jvh.14059.
4
Community-Based Point-of-Care Screening for Hepatitis B Virus and Hepatocellular Carcinoma in Rural Tanzania.坦桑尼亚农村地区基于社区的乙肝病毒和肝细胞癌即时检测筛查
Am J Trop Med Hyg. 2024 Nov 5;112(1):167-172. doi: 10.4269/ajtmh.24-0341. Print 2025 Jan 8.
5
Combined Hepatitis B Virus and Hepatocellular Carcinoma Screening Using Point-of-Care Testing and Ultrasound in a Tanzanian Emergency Department.在坦桑尼亚的急诊科，使用即时检测和超声进行乙型肝炎病毒和肝细胞癌联合筛查。
Am J Trop Med Hyg. 2024 Jan 9;110(2):399-403. doi: 10.4269/ajtmh.23-0365. Print 2024 Feb 7.
6
Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.环北极国家 2020 年乙型肝炎病毒消除状况和策略。
Int J Circumpolar Health. 2021 Dec;80(1):1986975. doi: 10.1080/22423982.2021.1986975.
7
Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.慢性病毒性肝炎综合管理的进展与挑战：消除的关键途径。
World J Gastroenterol. 2021 Jul 14;27(26):4004-4017. doi: 10.3748/wjg.v27.i26.4004.
8
Global Epidemiology of Chronic Liver Disease.慢性肝病的全球流行病学
Clin Liver Dis (Hoboken). 2021 Jun 4;17(5):365-370. doi: 10.1002/cld.1061. eCollection 2021 May.
9
Improving Hepatitis B Care in the US: A Case for a New "Ryan White" Program.改善美国的乙型肝炎护理：建立新的“瑞安·怀特”计划的理由。
J Health Care Poor Underserved. 2020;31(3):1037-1043. doi: 10.1353/hpu.2020.0077.
本文引用的文献
1
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担：全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
2
AASLD guidelines for treatment of chronic hepatitis B.美国肝病研究学会慢性乙型肝炎治疗指南。
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
3
Chronic hepatitis B virus infection.慢性乙型肝炎病毒感染。
Med Clin North Am. 2014 Jan;98(1):39-54. doi: 10.1016/j.mcna.2013.08.004. Epub 2013 Oct 20.
4
Updated CDC recommendations for the management of hepatitis B virus-infected health-care providers and students.美国疾病预防控制中心更新了乙型肝炎病毒感染者医护人员和学生管理建议。
MMWR Recomm Rep. 2012 Jul 6;61(RR-3):1-12.
Zotero 插件